Patent · US Active

N-glycinsulfonamide derivatives and uses as orexin receptor antagonists

US8003654B2 · kind B2 · utility

4Cited by

3References

12Claims

0Family size

Assignee

Actelion Pharmaceuticals Ltd. · CH

Inventors

Hamed Aissaoui · Allschwil, CH
Christoph Boss · Allschwil, CH
Markus Gude · Allschwil, CH
Ralf Koberstein · Bad Kötzting, DE
Thierry Sifferlen · Allschwil, CH
Cornelia Zumbrunn Acklin · Basel, CH

Key dates

Filing date	Apr 10, 2007
Grant date	Aug 23, 2011
Priority date	—
Expiry date	Dec 3, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to novel sulfonamide compounds of the formula (I)and their use as orexin receptor antagonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.